IRWD Q1 2019 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

Q1 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$69M-0.6% YoY

Gross Profit

$68M98.5% margin

Operating Income

-$54M-79.1% margin

Net Income

-$59M-86.3% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-47.4%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$46M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$364M

Total Liabilities

$601M

Stockholders' Equity

-$237M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$69M	-0.6%
Gross Profit	$68M	$67M	+1.7%
Operating Income	-$54M	-$36M	-51.6%
Net Income	-$59M	-$43M	-37.4%

Revenue Segments

Active Pharmaceutical Ingredient

$3M100%

Geographic Segments

J

$3M100%